Evidence map›Paper›PMID 30604150›Full record

SynthesisJournal of nephrology2019

Incremental dialysis in ESRD: systematic review and meta-analysis.

Carlo Garofalo, Silvio Borrelli, Toni De Stefano, Michele Provenzano, Michele Andreucci, Gianfranca Cabiddu, Vincenzo La Milia, Valerio Vizzardi, Massimo Sandrini, Giovanni Cancarini and 7 more

Registry-linked trialAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05721404 (Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis), which is not on this map. Cited by 57 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05721404 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis: A Randomized Controlled Trial

TypeinterventionalSponsorFirst Affiliated Hospital, Sun Yat-Sen UniversityRan2023 to 2027Enrolled194ConditionsPeritoneal DialysisArmsIcodextrin Peritoneal Dialysis Solution, Hypertonic Dextrose solution
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Pooled it
  4. Pooled it
  5. Trial
  6. Ten tips for the first hemodialysis sessions.Clinical kidney journal · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Observational
  15. Article
  16. Article
  17. Shared decision making in elderly patients with kidney failure.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  18. Article
  19. Article
  20. Incremental dialysis: two complementary views.Clinical kidney journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Carlo GarofaloDivision of Nephrology, Department of Scienze Mediche e Chirurgiche Avanzate, University of Campania "Luigi Vanvitelli", Via M. Longo 50, 80138, Naples, Italy. carlo.garofalo@hotmail.it.
Silvio BorrelliDivision of Nephrology, Department of Scienze Mediche e Chirurgiche Avanzate, University of Campania "Luigi Vanvitelli", Via M. Longo 50, 80138, Naples, Italy.
Toni De StefanoDivision of Nephrology, Department of Scienze Mediche e Chirurgiche Avanzate, University of Campania "Luigi Vanvitelli", Via M. Longo 50, 80138, Naples, Italy.
Michele ProvenzanoNephrology and Dialysis Division, University Magna Graecia in Catanzaro, Catanzaro, Italy.
Michele AndreucciNephrology and Dialysis Division, University Magna Graecia in Catanzaro, Catanzaro, Italy.
Gianfranca CabidduNephrology and Dialysis Division, G. Brotzu Hospital, Cagliari, Italy.
Vincenzo La MiliaNephrology and Dialysis Division, E. Bassini Hospital, Cinisello Balsamo, Milan, Italy.
Valerio VizzardiNephrology and Dialysis Division, ASST Spedali Civili and University of Brescia, Brescia, Italy.
Massimo SandriniNephrology and Dialysis Division, ASST Spedali Civili and University of Brescia, Brescia, Italy.
Giovanni CancariniNephrology and Dialysis Division, ASST Spedali Civili and University of Brescia, Brescia, Italy.
Adamasco CupistiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Vincenzo BellizziRuggi d'Aragona Hospital in Salerno, Bari, Italy.
Roberto RussoAzienda Ospedaliera Universitaria Policlinico, Bari, Italy.
Paolo ChiodiniStatistic and Epidemiologic Division, University L. Vanvitelli in Naples, Naples, Italy.
Roberto MinutoloDivision of Nephrology, Department of Scienze Mediche e Chirurgiche Avanzate, University of Campania "Luigi Vanvitelli", Via M. Longo 50, 80138, Naples, Italy.
Giuseppe ConteDivision of Nephrology, Department of Scienze Mediche e Chirurgiche Avanzate, University of Campania "Luigi Vanvitelli", Via M. Longo 50, 80138, Naples, Italy.
Luca De NicolaDivision of Nephrology, Department of Scienze Mediche e Chirurgiche Avanzate, University of Campania "Luigi Vanvitelli", Via M. Longo 50, 80138, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncremental dialysis may preserve residual renal function and improve survival in comparison with full-dose dialysis; however, available evidence is limited. We therefore compared all-cause mortality and residual kidney function (RKF) loss in incremental and full-dose dialysis and time to full-dose dialysis in incremental hemodialysis (IHD) and incremental peritoneal dialysis (IPD).

methodsWe performed a systematic review and meta-analysis of cohort studies of adults with ESRD starting IHD and IPD. We identified in PubMed and Web of Science database all cohort studies evaluating incremental dialysis evaluating three outcomes: all-cause mortality, RKF loss, time to full dialysis. IPD was defined as < 3 daily dwells in Continuous Ambulatory Peritoneal Dialysis and < 5 sessions per week in Automated Peritoneal Dialysis, while IHD was defined as < 3 HD sessions per week.

results22 studies (75,292 participants), 15 in HD and 7 in PD, were analyzed. Mean age at dialysis start was 62 and 57 years in IHD and IPD subjects, respectively. When compared to full dose, incremental dialysis (IHD or IPD) had an overall mortality risk of 1.14 [95% CI 0.85-1.52] with high heterogeneity among studies (I

conclusionsIncremental dialysis allows longer preservation of RKF thus deferring full-dose dialysis, by about 1 year in HD and PD, with no increase in mortality risk. Large and adequate studies are needed to confirm these findings.

Indexed as

Cause of DeathCohort StudiesHumansKidney Failure, ChronicPeritoneal DialysisRenal DialysisESRDIncremental hemodialysisIncremental peritoneal dialysisMeta-analysisSystematic review

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.